Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) currently has a daily average trading volume of 686.52K but it saw 21283142 shares traded in last market. With a market cap of 17.19M USD, the company’s current market price of $0.36 came falling about -53.12 while comparing to the previous closing price of $0.76. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.28 and as low as $0.49. In the recent trading on the day, stock has struck highest price mark of $0.3 while lowest mark touched by it was $0.4616.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the ROTH MKM which initiated the stock as “Buy” in its note to investors issued on September 20, 2023, recommending a price target of $12 for it. H.C. Wainwright also issued its recommendations for the stock as it initiated the price target for the stock is $10.
Over the week, RVPH’s stock price is moving -46.88% down while it is -67.45% when we observe its performance for the past one month. Year-to-date it is -72.03% down and over the past year, the stock is showing a downside performance of -80.22%.
The company is expected to be releasing its next quarterly report on 2025-May-15, for which analysts forecasted an EPS of -0.11 while estimate for next year EPS is -0.5.
Currently, Reviva Pharmaceuticals Holdings Inc’s total number of outstanding shares is 46.74M with 10.58% of that held by the insiders while 20.90% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -916.17%. Stock’s beta reads 0.08. Its return on asset (ROA) is -281.12% on average.
